NC Testing in LC & POTS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Calgary

About this trial

Patients with Postural Orthostatic Tachycardia Syndrome (POTS) and Post-Acute Sequelae of COVID (PASC, or "Long COVID") experience cognitive dysfunction. The investigators will test the hypothesis that 999 mL of IV saline will improve cognitive function in patients with POTS and Long COVID compared to placebo (50 mL of saline).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with diagnosis of Long COVID

SARS-COV2 test positive

Symptoms > 12 weeks post COVID

Subjective complaint of 'brain fog" or cognitive dysfunction

Disqualifiers

Patients with overt causes for POTS (e.g., dehydration, prolonged bed rest)

An inability to safely withdraw from medicine(s) that could make test interpretation difficult and impossible.

Other factors which are in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies or an unpredictable schedule.

Unable to give an informed consent.

Trial design

Design model

Crossover

Treatments tested in this trial

  • IV normal saline (999 mL infusion)

    Other intervention

    999 mL of IV normal saline will be infused intravenously

  • IV normal saline (50 mL infusion)

    Other intervention

    50 mL of IV normal saline will be infused intravenously as a placebo control.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: 999 mL normal SalineExperimental treatment 1 intervention
Group B: 50 mL normal SalinePlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

5RTI Reaction Time task (Standing)

5RTI Reaction Time Score (Standing) after 999 mL IV saline compared to 5RTI score after 50 mL IV saline measured in milliseconds (ms). The minimum score is 100 ms and the maximum score is 5100 ms. A longer time is a worse outcome.

Time frame
During Procedure (3 hours)

Secondary outcomes

1

Reaction Time Test (Psychomotor Speed)

Reaction Time Test score after 1500mL IV saline compared to after 50mL IV saline measured in milliseconds. The minimum score is 100 ms and the maximum score is 5100 ms. A longer time is a worse outcome.

Time frame
During Procedure (3 hours)
2

Paired Associates Learning (Visual Episodic Memory)

Paired Associates Learning score after 999 mL IV saline compared to after 50 mL IV saline measured in arbitrary units. The minimum score is 0 and the maximum score is 70. A higher score is a worse outcome.

Time frame
During Procedure (3 hours)
3

Verbal Recognition Memory (Verbal memory)

Verbal Recognition Memory test score after 999 mL IV saline compared to after 50 mL IV saline. The range is 0-18. A higher score is a better outcome.

Time frame
During Procedure (3 hours)
4

Multitasking Test (Executive Function - Inhibition)

Multitasking Test Time after 999 mL IV saline compared to after 50 mL IV saline measured in ms. The range is 100 - 2000 ms. A longer time is a worse is a worse outcome.

Time frame
During Procedure (3 hours)

Other outcomes

1

Sitting heart rate

Sitting heart rate after 999 mL IV saline compared to after 50 mL IV saline.

Time frame
During Procedure (10 minutes)
2

Standing heart rate

Standing heart rate after 999 mL IV saline compared to after 50 mL IV saline.

Time frame
During Procedure (10 minutes)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.